StartsideBAX • NYSE
add
Baxter International Inc
29,99 $
Etterbørs:(0,00 %)0,00
29,99 $
Stengt: 20. juni, 18:05:07 GMT-4 · USD · NYSE · Ansvarsfraskrivelse
Forrige sluttkurs
29,80 $
Dagsintervall
29,78 $ - 30,19 $
Årsintervall
26,25 $ - 40,49 $
Markedsverdi
15,39 mrd. USD
Gjennomsnittlig volum
3,45 mill.
P/E-tall
-
Utbytte
2,27 %
Hovedbørs
NYSE
I nyhetene
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
| (USD) | mars 2025info | Endring år til år |
|---|---|---|
Omsetning | 2,62 mrd. | 5,42 % |
Driftskostnader | 732,00 mill. | −9,85 % |
Nettoomsetning | 126,00 mill. | 240,54 % |
Netto resultatmargin | 4,80 | 222,15 % |
Fortjeneste per aksje | 0,55 | −15,38 % |
EBITDA | 503,00 mill. | 16,17 % |
Faktisk avgiftssats | 2 233,33 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
| (USD) | mars 2025info | Endring år til år |
|---|---|---|
Kontant / kortsiktige inv. | 2,29 mrd. | −24,19 % |
Totale aktiva | 21,30 mrd. | −23,33 % |
Totale passiva | 14,25 mrd. | −27,12 % |
Total egenkapital | 7,05 mrd. | — |
Utestående aksjer | 513,17 mill. | — |
P/B-forhold | 2,16 | — |
Avkastning på aktiva | 2,72 % | — |
Avkastning på kapital | 3,38 % | — |
Kontantstrøm
Netto kontantstrøm
| (USD) | mars 2025info | Endring år til år |
|---|---|---|
Nettoomsetning | 126,00 mill. | 240,54 % |
Kontantstrøm fra drift | −193,00 mill. | −218,40 % |
Kontanter fra investering | 3,26 mrd. | 2 066,87 % |
Kontanter fra finansiering | −3,23 mrd. | −2 204,29 % |
Netto kontantstrøm | −118,00 mill. | 29,76 % |
Fri kontantstrøm | 1,73 mrd. | 395,14 % |
Om
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Administrerende direktør
Grunnlagt
1931
Hovedkvarter
Nettsted
Ansatte
38 000
